RefleXion Medical announced today that it signed a licensing agreement with Limbus AI to incorporate software into radiation treatment planning. The agreement enables the integration of the Limbus Contour automated contour software into the RefleXion X1 system. X1 uses biology-guided radiotherapy (BgRT) technology. It enables a PET radiotracer to create a unified motion management solution […]
Radiosurgery/Radiation therapy
PathKeeper Surgical, Mayo Clinic sign know-how agreement for pediatric spine surgery radiation research
PathKeeper Surgical has entered into a know-how agreement with the Mayo Clinic to research radiation levels in pediatric spine surgeries. The research will focus on reducing patient radiation exposure using minimally invasive optical navigation and using intraoperative measurement tools for scoliosis correction. Mayo Clinic pediatric spine surgeons Drs. Noelle Larson and Todd Milbrandt are collaborating […]
NeuroOne begins neuroablation system launch in U.S.
NeuroOne Medical Technologies (Nasdaq:NMTC) announced today that it initiated a limited commercial launch for its OneRF ablation system. The Eden Prairie, Minnesota–based company said its initial rollout comes earlier than it previously expected. It picked up FDA 510(k) clearance for the OneRF system just over three months ago in December 2023. Indications cover the creation […]
Medtronic wins FDA clearance for bone tumor ablation tech
Medtronic announced today that it received FDA 510(k) clearance for its OsteoCool 2.0 bone tumor ablation system. The medtech giant designed OsteoCool 2.0 to treat painful bone metastases and benign bone tumors like osteoid osteoma. The minimally invasive procedure uses probes to deliver radiofrequency energy that heats and destroys tumors. Meanwhile, it circulates water to […]
FDA clears neuro ablation tech from NeuroOne
NeuroOne Medical Technologies (Nasdaq:NMTC) announced today that the FDA granted 510(k) clearance to its OneRF ablation system. Clearance makes OneRF the first FDA-cleared, thin-film, sEEG-guided radiofrequency (RF) system capable of recording electrical activity and ablating nervous tissue. The system, which also features temperature control, became the third FDA-cleared device at NeuroOne. It’s the first therapeutic […]
Boston Scientific closes Relievant Medsystems acquisition
Boston Scientific announced today that it completed its previously announced acquisition of Relievant Medsystems. In September, Boston Scientific announced plans to acquire Relievant for an upfront cash payment of $850 million. Additional payments are contingent on sales performance over the next three years. Minneapolis-based Relievant developed and commercialized the Intracept intraosseous nerve ablation system for […]
Elekta receives $40M radiation tech order in India
Elekta announced today that it received an order worth approximately $40 million for its full suite of hardware and software. Stockholm, Sweden-based Elekta develops precision radiation therapy to treat cancer. The FDA cleared its latest offering, the Comprehensive Motion Management (CMM) with True Tracking and automatic gating, earlier this year. Krishna Institute of Medical Sciences […]
NeuroOne expects FDA nod for neuro ablation tech next year
NeuroOne (Nasdaq:NMTC) announced today that it responded to FDA questions regarding the 510(k) submission of its OneRF ablation system. Eden Prairie, Minnesota–based NeuroOne submitted OneRF for FDA clearance in June. It’s the company’s first therapeutic device. The technology uses already-implanted sEEG electrodes to record brain activity and enable the ablation of nervous tissue. It connects […]
Relievant Medsystems unveils Intracept simulation training program
Relievant Medsystems announced today that it released its Intracept simulator system, a training platform for the Intracept procedure. Further progress for Relievant and Intracept follows Tuesday’s major news of an agreement for Boston Scientific to acquire the company. Boston Scientific officials went into further detail on their expectations for the Relievant deal at the company’s […]
Boston Scientific to acquire nerve ablation tech developer Relievant Medsystems for $850M
Boston Scientific announced today that it entered into a definitive agreement to acquire Relievant Medsystems. The transaction includes an upfront cash payment of $850 million. Additional payments are contingent on sales performance over the next three years. Minneapolis-based Relievant developed and commercialized the Intracept intraosseous nerve ablation system for chronic pain. The minimally invasive, FDA-cleared, […]
Radiaction raises $12.6M for radiation protection tech
Radiaction Medical announced today that it raised $12.6 million in Series C2 funding and elected Christopher Barys to its board. U.S. private equity fund InnovaHealth Partners led the Tel Aviv, Israel-based company’s round. Additional unnamed co-investors participated. Radiaction develops a novel system designed to proactively block radiation from the source. It provides comprehensive, head-to-toe radiation protection […]